AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vigroz MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Zylig Lifesciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Vigroz MV 1mg/500mg/0.2mg Tablet

Diabetol-Triple 1mg/500mg/0.2mg tablets are classified as antidiabetic medications, combining multiple agents to manage type 2 diabetes in adults. This formulation aids in regulating blood glucose. Diabetol-Triple should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Uses of Vigroz MV 1mg/500mg/0.2mg Tablet

Managing Type 2 Diabetes

Major Benefits of Vigroz MV 1mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vigroz MV 1mg/500mg/0.2mg tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Vigroz MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Vigroz MV 1mg/500mg/0.2mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Vigroz MV 1mg/500mg/0.2mg tablet on an empty stomach.

How Vigroz MV 1mg/500mg/0.2mg Tablet works:

One tablet of Vigroz MV contains 1mg, 500mg, and 0.2mg of three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vigroz MV 1mg/500mg/0.2mg Tablet with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vigroz MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Vigroz MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Vigroz MV 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Vigroz MV 1mg/500mg/0.2mg Tablets is contraindicated in those with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Vigroz MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, the medication is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Vigroz MV 1mg/500mg/0.2mg Tablet :

Should you forget to take a Vigroz MV 1mg/500mg/0.2mg Tablet, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Vigroz MV 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vigroz MV 1mg/500mg/0.2mg Tablet

Vigroz MV 1mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This treatment improves blood glucose control when combined with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Vigroz MV 1mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, stomach pain, headache, rash, and respiratory infection.
Vigroz MV 1mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any component or excipient. They should also be avoided in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Vigroz MV 1mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Vigroz MV 1mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Vigroz MV 1mg/500mg/0.2mg...
134
MRP 155
13% off